FDA Import Refusal AEK-7307295-9/22/1 — GLENMARK PHARMA
The FDA refused shipment AEK-7307295-9/22/1 from GLENMARK PHARMA (India) on Jul 21, 2025. The refused product falls under Drugs and Biologics — SITAGLIPTIN PHOSPHATE (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Jul 21, 2025
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61PDY68 SITAGLIPTIN PHOSPHATE (ANTI-DIABETIC)
- Charges
- 75